Evidence map›Paper›PMID 25840857›Full record

ArticleGenome research2015

The 100-genomes strains, an S. cerevisiae resource that illuminates its natural phenotypic and genotypic variation and emergence as an opportunistic pathogen.

Pooja K Strope, Daniel A Skelly, Stanislav G Kozmin, Gayathri Mahadevan, Eric A Stone, Paul M Magwene, Fred S Dietrich, John H McCusker

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 222 papers.

0numbers the graph read from it
0cells of the map it votes in
222citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

222 citing papers in PubMed, 381 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Domestication drives repeated evolution of sexual-asexual life cycle trade-offs in yeast.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Phylogenomic diversity of clinicalMicrobiology spectrum · 2026
    Article
  15. Review
  16. Review
  17. Surprising regulatory plasticity for the conserved HOG pathway in diversebioRxiv : the preprint server for biology · 2025
    Article
  18. Review
  19. Article
  20. Article

162 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Pooja K StropeDuke University Medical Center, Department of Molecular Genetics and Microbiology, Durham, North Carolina 27710, USA;
Daniel A SkellyDepartment of Biology, Duke University, Durham, North Carolina 27710, USA;
Stanislav G KozminDuke University Medical Center, Department of Molecular Genetics and Microbiology, Durham, North Carolina 27710, USA;
Gayathri MahadevanDuke University Medical Center, Department of Molecular Genetics and Microbiology, Durham, North Carolina 27710, USA;
Eric A StoneDepartment of Biological Sciences, North Carolina State University, Raleigh, North Carolina 27695, USA.
Paul M MagweneDepartment of Biology, Duke University, Durham, North Carolina 27710, USA;
Fred S DietrichDuke University Medical Center, Department of Molecular Genetics and Microbiology, Durham, North Carolina 27710, USA;
John H McCuskerDuke University Medical Center, Department of Molecular Genetics and Microbiology, Durham, North Carolina 27710, USA;
Duke University · USNorth Carolina State University · US

Funding

Tri-Institutional Molecular Mycology and Pathogenesis Training ProgramT32AI052080 · NIAID · DUKE UNIVERSITY · PI ANDREW ALSPAUGH, JOSEPH HEITMAN · 2003 to 2026
$8.7M
High throughput S. cerevisiae HAM, GWA & QT/QTL architectureR01GM098287 · NIGMS · DUKE UNIVERSITY · PI DIETRICH, FRED S, MAGWENE, PAUL MITAARI · 2011 to 2014
$2.1M
NIAID NIH HHS T32 AI052080NIAID NIH HHS T32 AI052080-11NIGMS NIH HHS R01 GM098287
6 · The paper itself

Abstract

Saccharomyces cerevisiae, a well-established model for species as diverse as humans and pathogenic fungi, is more recently a model for population and quantitative genetics. S. cerevisiae is found in multiple environments-one of which is the human body-as an opportunistic pathogen. To aid in the understanding of the S. cerevisiae population and quantitative genetics, as well as its emergence as an opportunistic pathogen, we sequenced, de novo assembled, and extensively manually edited and annotated the genomes of 93 S. cerevisiae strains from multiple geographic and environmental origins, including many clinical origin strains. These 93 S. cerevisiae strains, the genomes of which are near-reference quality, together with seven previously sequenced strains, constitute a novel genetic resource, the "100-genomes" strains. Our sequencing coverage, high-quality assemblies, and annotation provide unprecedented opportunities for detailed interrogation of complex genomic loci, examples of which we demonstrate. We found most phenotypic variation to be quantitative and identified population, genotype, and phenotype associations. Importantly, we identified clinical origin associations. For example, we found that an introgressed PDR5 was present exclusively in clinical origin mosaic group strains; that the mosaic group was significantly enriched for clinical origin strains; and that clinical origin strains were much more copper resistant, suggesting that copper resistance contributes to fitness in the human host. The 100-genomes strains are a novel, multipurpose resource to advance the study of S. cerevisiae population genetics, quantitative genetics, and the emergence of an opportunistic pathogen.

Indexed as

Genome, FungalGenotypePhenotypePolymorphism, GeneticContig MappingPhylogenySaccharomyces cerevisiaeSequence AlignmentVirulence

Identifiers

PMID25840857
PMCPMC4417123
OpenAlexW1979914496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.